Genetically-engineered preclinical models predict pharmacodynamic response
Wednesday, September 19, 2012 - 21:00
in Health & Medicine
A new comparison of four different methodologies for pharmacokinetic and pharmacodynamic testing of the anti-melanoma agent carboplatin, demonstrates that genetically-engineered mouse models provide tumor delivery of drug most comparable to the response seen in melanoma patients.